Indirect treatment comparison of two pulsed field ablation systems for the treatment of persistent atrial fibrillation
PFA is generally safe and efficient; however, in this ITC, SPHERE Per-AF showed a higher probability of treatment success in PerAF patients compared to ADVANTAGE AF. Overall, these results underline possible differences even amongst PFA systems, which must be validated in randomized trials. Until then, MAIC methods fill the current evidence gap. Registry and the Registration No. SPHERE Per-AF: NCT05120193 and ADVANTAGE AF: NCT05443594.
Authors
- Kazuo Matsumoto (ORCID: https://orcid.org/0000-0001-8131-7736)
- Kelly A. van Bragt (ORCID: https://orcid.org/0000-0003-4118-4291)
- Waruiru Mburu (ORCID: https://orcid.org/0000-0003-3870-9173)
- Fred Kueffer (ORCID: https://orcid.org/0009-0004-1447-8811)
- Khaldoun G. Tarakji (ORCID: https://orcid.org/0000-0002-3662-2886)
Institutions
- Medtronic (Ireland) (IE)
- Medtronic (United States) (US)
- Saitama Medical University Hospital (JP)
- Saiseikai Matsuyama Hospital (JP)
- Medtronic (Germany) (DE)
Publication Details
- Journal
- Journal of Interventional Cardiac Electrophysiology
- Published
- 2025-09-10
- DOI
- https://doi.org/10.1007/s10840-025-02124-6
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00